Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
2019 BIO INTERNATIONAL CONVENTION EVENT SUMMARY
JUNE 3-6, 2019 • PHILADELPHIA, PA • #BIO2019
IT STARTS WITH NE
convention.bio.org
1,800+ EXHIBITORS
46 DOMESTIC
+ INTERNATIONAL PAVILIONS
75 ORGANIZATIONS
IN THE BIO PATIENT ADVOCACY PAVILION
800+ SPEAKERS
150+ SESSIONS
18 EDUCATION
TRACKS
250+ COMPANY
PRESENTATIONS
16 SUPER SESSIONS
AND FIRESIDE CHATS
50 START-UP STADIUM
PRESENTERS
including Company Presentations + Start-Up Stadium participants
48,500+ PARTNERING MEETINGS BETWEEN
7,796 DELEGATES
FROM
4,102 COMPANIES
BIO 2019 by the Numbers
17,307 ATTENDEES
FROM
65 COUNTRIES
49 STATES, DC, AND PUERTO RICO
8,400+ COMPANIES
25% FIRST TIME ATTENDEES
100+ INTERNATIONAL AND US
PUBLIC OFFICIALS
153 STUDENT DAY PARTICIPANTS
convention.bio.org
BREAKDOWN BY TITLE
24% CEO/C-Level23% VP/Partner/Managing Director44% Director/Mid-Level Manager5% Coordinator2% Educator/University Faculty/Students2% Public Official/Foreign Minister
44%
24%
23%
5%
2% 2%
Attendance History
15,667ATTENDEES
2014SAN DIEGO
15,858ATTENDEES
2015PHILADELPHIA
16,123ATTENDEES
2017SAN DIEGO
18,289ATTENDEES
2018BOSTON
17,307ATTENDEES
2019PHILADELPHIA
15,937ATTENDEES
2016SAN FRANCISCO
4,366FIRST TIME ATTENDEES
IN 2019 (24%)
convention.bio.org
COMPANY SIZE (Based on number of employees)
PRIMARY JOB ROLE OF ATTENDEES
27% Executive42% Business Development/Sales10% Researcher/ Scientist6% Consulting Services5% Attorney/General Counsel/Associate5% Policy/Government Affairs/Advocacy5% Marketing/PR
Top 10 COMPANY TYPES REPRESENTED
1. Clinical
2. Market – Drug (on patent)
3. Preclinical
4. Consulting
5. Legal
6. University (Faculty)
7. Research Institute
8. Research Technology
9. CRO & Analytical Labs
10. Tech Transfer
Attendee Stats
PURCHASE INFLUENCE
42%
1 – 50
8%
51 – 100
11%
101 – 300
7%
301 – 500
32%
500+
61% OF ATTENDEES HAVE INFLUENCE OVER PURCHASES MADE FOR THEIR COMPANY
42%
27%
10%
6%5%
5%5%
convention.bio.org
International Attendee Stats
1 Canada
2 South Korea
3 United Kingdom
4 Japan
5 Germany
6 China
7 Taiwan
8 France
9 Australia
10 Brazil
65COUNTRIES
49STATES
38%OF ATTENDEES ARE
INTERNATIONAL
TOP 10 INTERNATIONAL DELEGATIONS
EVALUATE products/services for
purchase or investment
SEARCH for new/emerging
technologies
ATTEND company presentations and education sessions
TOP REASONS to Attend BIO
NETWORK & PARTNER with attendees and exhibitors
48,500
Partnering Activity Has
Grown 66% in the last 5 years
World's Largest Biotech
Partnering Event
WORLD'S LARGEST BIOTECH PARTNERING EVENT
7,796
4,102
convention.bio.org
NUMBER OF MEETINGS
NUMBER OF COMPANIES
NUMBER OF DELEGATES
BIO One-on-One PartneringTM
PHILADELPHIA SAN FRANCISCO SAN DIEGO BOSTON PHILADELPHIA
convention.bio.org
ACADEMIC CAMPUS
FEATURED UNIVERSITIES AND RESEARCH INSTITUTIONS
San Diego Innovation Council
21 UNIVERSITIES
124 TOTAL PARTICIPANTS
800+ SPEAKERS
150+ SESSIONS
18 EDUCATION
TRACKS
250+ COMPANY
PRESENTATIONS
16 SUPER SESSIONS
AND FIRESIDE CHATS
50 START-UP STADIUM
PRESENTERS
including Company Presentations + Start-Up Stadium participants
convention.bio.org
Education Program – Education Tracks
BIOFUELS & RENEWABLE CHEMICALS TRACK BRAIN HEALTH TRACK BUSINESS DEVELOPMENT &
FINANCE TRACK
DIGITAL HEALTH TRACK EMERGING OPPORTUNITIES IN GLOBAL MARKETS TRACK
GENOME EDITING TRACK HIGHLY PREVALENT CHRONIC DISEASES TRACK – NEW!
INFECTIOUS DISEASES & VACCINES TRACK
INTELLECTUAL PROPERTY TRACK
NEXT GENERATION BIOTHERAPEUTICS TRACK
ONCOLOGY TRACK
OPIOIDS: CHANGING THE PARADIGM ON TREATING PAIN
ORPHAN & RARE DISEASES TRACK
PATIENT ADVOCACY TRACK – NEW!
PERSONALIZED MEDICINE & DIAGNOSTICS TRACK
REGULATORY INNOVATION TRACK
TRANSLATIONAL RESEARCH TRACK
VALUE, PATIENT ACCESS, & COMMERCIALIZATION TRACK
What’s Next: The Landscape of Innovation in 2019 and Beyond
Digital Health in Practice: A Conversation with Ameet Nathwani, Chief Digital Officer, Chief Medical Officer and Member of the Executive Committee, Sanofi
Falling in Love with Science: Championing Science for Everyone, Everywhere
Biotech’s Contribution to Innovation: Current and Future Drivers of Success
Realizing the Promise of Gene Therapies for Patients Around the World
Dealmakers’ Intentions: 2019 Market Outlook
The Art & Science of R&D Innovation and Productivity
The State of the Vaccine Industry: Stimulating Sustainable Growth
Nature Biotechnology and Scientific American WORLDVIEW: Biotech Innovation in a Faster Future
convention.bio.org
Education Program – Super Sessions
convention.bio.org
Peter Marks, MD, PhDDirector of the Center for Biologics Evaluation and Research (CBER) at U.S. Food and Drug Administration
John MaraganoreChief Executive Officer at Alnylam Pharmaceuticals
Janet Woodcock, MDDirector of the Center for Drug
Evaluation and Research (CDER) at U.S. Food And Drug Administration (FDA)
Jeffrey SolomonChief Executive Officer at COWEN
Jeremy LevinCEO, Chairman at Ovid Therapeutics
Norman Sharpless, MDActing Commissioner,
US Food & Drug Administration
Christi ShawSenior Vice President and President,
Lilly BIO-Medicines, Eli Lilly and Company
Meg TirrellBiotech and Pharma Reporter at CNBC
Kenneth C. FrazierChairman of the Board and Chief
Executive Officer at Merck & Co, Inc.
Julie Gerberding, MD, PhDExecutive Vice President & Chief
Patient Officer at Merck & Co, Inc.
Christopher AnselmoMarket Intelligence Manager at Muscular Dystrophy Association
Eve BukowskiVice President, Patient Advocacy,
Education & Outreach atCalifornia Life Sciences Association (CLSA)
Emily Kramer-GolinkoffCo-Founder at Emily’s Entourage
Margaret (Peggy) Hamburg, MDForeign Secretary, National Academy
of Medicine at Chairman of the Board, American Association for the
Advancement of Science
Education Program – Fireside Chat Speakers
convention.bio.org
Next Generation Biotherapeutics
Business Development & Finance
Oncology
What’s Next: The Landscape of Innovation in 2019 and Beyond
Gene Therapy 2.0: No Longer Science Fiction
Fireside Chat with Kenneth C. Frazier, Chairman of the Board and Chief Executive Officer, Merck & Co., Inc.
Dealmakers’ Intentions: 2019 Market Outlook
Top 3 Attended TracksTop 4 Attended Sessions
Education Program
convention.bio.org
Education Program – Diversity of Experts
Maina BhamanPartner, Capital Funds
Sofinnova Partners
Roger ConnorPresident, GSK Vaccines
GlaxoSmithKline
Debra MillerChief Executive Officer
and Founder CureDuchenne
Seema KumarVice President, Innovation, Global Health
and Policy Communication Johnson & Johnson Innovation (Moderator)
Neel PatelManaging Director,
Portfolio & Commercial Strategy Syneos Health
(Moderator & Presenter)
Sam UlinManaging Director
ClearView Healthcare Partners
Ameet NathwaniChief Digital Officer, Chief Medical Officer
and Member of the Executive Committee Sanofi
Saurabh SahaSenior Vice President R&D,
Global Head of Translational Medicine Bristol-Myers Squibb
Stacy LindleyVice President and Head of Emerging Biopharma
Alliance Management, IQVIA Biotech (Moderator)
convention.bio.org
2018Robin Roberts
Rob Reiner
2017David CameronAnn Romney
2016Will Smith
Dr. Benet Omalu
2015Tom Brokaw
Eric TopolWynton Marsalis
2014Hillary Clinton
Richard Branson
PREVIOUS KEYNOTE SPEAKERS
Siddhartha MukherjeePhysician, Biologist, Oncologist + Author
Jamie DimonChairman & CEO, JP Morgan Chase
Global Finance Leader
BIO 2019 Keynote Speakers
convention.bio.org
BIO ActionBIO Patient
Advocacy Pavilion BioProcess Zone
Contract Services ZoneInnovation Zone
Start-Up Stadium
BIO 2019 FEATURED
OVER 150 NEW EXHIBITORS
1,800+ EXHIBITORS
46DOMESTIC
+ INTERNATIONAL PAVILIONS
75 ORGANIZATIONS
IN THE BIO PATIENT ADVOCACY PAVILION
BIO Exhibition Overview
1 New Zealand
2 Poland
3 Uruguay
4 Welsh Government
4 NEW PAVILIONS
SPECIALTY ZONES & PAVILIONS
convention.bio.org
BIO 2019 Sponsors
DOUBLE HELIX
HELIX
convention.bio.org
BIO 2019 Sponsors
Alkermes
Alnylam Pharmaceuticals
Biogen
Boehringer Ingelheim Pharmaceuticals, Inc.
Chubb
Covance, Inc.
CSL Behring
Daiichi Sankyo
GlaxoSmithKline
IQVIA Biotech
Novartis
Retrophin
Sanofi Pasteur
Servier
Syneos Health
Takeda
VWR, Part of Avantor
Astellas Pharma Inc.
Elanco Animal Health
Foley Hoag LLP
GE Healthcare
Horizon Therapeutics
Inova Software
Locust Walk
Otsuka
Torreya
Abcam
Acceleron Pharma Inc.
Amarin Pharma Inc.
Asahi Kasei Pharma Corporation
BioInnovation Institute
Brii Biosciences
Celgene
City of Phoenix
Clarivate Analytics
Clinical Network Services (CNS) PTY LTD
Cooley LLP
Ferring Pharmaceuticals
Fujifilm Healthcare
Lupin, Inc.
MedChemBio
Pepper Hamilton LLP
Regeneron
Signals Analytics
State Government of Victoria, Australia
Trinity
Wells Fargo
PREMIER CHAMPION CONFERENCE
18
convention.bio.org
• JUNE 8-11, 2020 •
• SAN DIEGO •